In summary, NCTD effectively inhibits the malignant proliferation of colon cancer cells by regulating the TRAF5/NF-κB signaling pathway and inducing programmed apoptosis, offering a novel treatment strategy. This evidence concerns the gene TRAF5 and colonic neoplasm.